Inventor · disambiguated record
Behnam Nabet
Also filed as: NABET BEHNAM
5 granted patents·6 pending applications·8 citations·filing 2018–2022
69Inventor score
Files withDANA FARBER CANCER INST INC11
Top patents by PatentIndex Score
11 records- 0191US11311609B2Regulating chimeric antigen receptorsDANA FARBER CANCER INST INC·Filed 2018·Granted Apr 26, 2022·6 cites·29 claims
- 0286US11046954B2Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responsesDANA FARBER CANCER INST INC·Filed 2018·Granted Jun 29, 2021·2 cites·17 claims
- 0374US2022135967A1Tunable endogenous protein degradationDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0471US2021301286A1Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responsesDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 0568US11293023B2Tunable endogenous protein degradationDANA FARBER CANCER INST INC·Filed 2018·Granted Apr 5, 2022·0 cites·13 claims
- 0657US2025127783A1Inhibitors of the peptidyl-prolyl cis/trans isomerase (pin1), combinations and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0755US2025319053A1Inhibitors of the peptidyl-prolyl cis/trans isomerase (pin1), combinations and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0850US2022089589A1SMALL MOLECULE DEGRADERS OF FKBP12 VIA RECRUITMENT OF VON HIPPEL-LINDAU E3 UBIQUITIN LIGASE (VHL) E3 UBIQUITIN LIGASE, AND USES IN dTAG SYSTEMSDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 0950US2022040317A1Degradation of fak or fak and alk by conjugation of fak and alk inhibitors with e3 ligase ligands and methods of useDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1048US12023385B2Tunable endogenous protein degradation with heterobifunctional compoundsDANA FARBER CANCER INST INC·Filed 2018·Granted Jul 2, 2024·0 cites·24 claims
- 1144US12365696B2Small-molecule focal adhesion kinase (FAK) inhibitorsDANA FARBER CANCER INST INC·Filed 2020·Granted Jul 22, 2025·0 cites·26 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →